Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.

Clinical trial NCT00311363 · COMPLETED

Trial details

NCT number: NCT00311363
Sponsor: XenoPort, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2006-04-01
Primary completion: 2007-11-01
Enrollment: 327

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.